<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30042931</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>12</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>12</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2235-2988</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Frontiers in cellular and infection microbiology</Title><ISOAbbreviation>Front Cell Infect Microbiol</ISOAbbreviation></Journal><ArticleTitle>DC-SIGN Binding Contributed by an Extra N-Linked Glycosylation on Japanese Encephalitis Virus Envelope Protein Reduces the Ability of Viral Brain Invasion.</ArticleTitle><Pagination><StartPage>239</StartPage><MedlinePgn>239</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">239</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcimb.2018.00239</ELocationID><Abstract><AbstractText>The major structural envelope (E) protein of Japanese encephalitis virus (JEV) facilitates cellular binding/entry and is the primary target of neutralizing antibodies. JEV E protein has one N-linked glycosylation site at N154 (G2 site), but the related dengue virus E protein has two glycosylation sites at N67 (G1 site) and N153 (G2 site). We generated three recombinant JEVs with different glycosylation patterns on the E protein. As compared with wild-type (WT) JEV with G2 glycosylation, viral growth in culture cells as well as neurovirulence and neuroinvasiveness in challenged mice were reduced when infected with the G1 mutant (E-D67N/N154A) with glycosylation shifted to G1 site, and the G0 mutant (E-N154A) with non-glycosylation. The G1G2 mutant (E-D67N), with E-glycosylation on both G1 and G2 sites, showed potent <i>in vitro</i> viral replication and <i>in vivo</i> neurovirulence, but reduced neuroinvasiveness. Furthermore, the JEV mutants with G1 glycosylation showed enhanced DC-SIGN binding, which may then lead to reduced brain invasion and explain the reason why WT JEV is devoid of this G1 site of glycosylation. Overall, the patterns of N-linked glycosylation on JEV E proteins may affect viral interaction with cellular lectins and contribute to viral replication and pathogenesis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Jian-Jong</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chou</LastName><ForeName>Min-Wei</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yi-Ling</ForeName><Initials>YL</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Genomics Research Center, Academia Sinica, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>07</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cell Infect Microbiol</MedlineTA><NlmUniqueID>101585359</NlmUniqueID><ISSNLinking>2235-2988</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015815">Cell Adhesion Molecules</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C405948">DC-specific ICAM-3 grabbing nonintegrin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D037181">Lectins, C-Type</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011956">Receptors, Cell Surface</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014759">Viral Envelope Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C080628">glycoprotein E, Japanese encephalitis virus</NameOfSubstance></Chemical></ChemicalList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015815" MajorTopicYN="N">Cell Adhesion Molecules</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004664" MajorTopicYN="N">Encephalitis Virus, Japanese</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004672" MajorTopicYN="N">Encephalitis, Japanese</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006031" MajorTopicYN="N">Glycosylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="Y">Host-Pathogen Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D037181" MajorTopicYN="N">Lectins, C-Type</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011956" MajorTopicYN="N">Receptors, Cell Surface</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014759" MajorTopicYN="N">Viral Envelope Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014774" MajorTopicYN="N">Virulence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DC-SIGN</Keyword><Keyword MajorTopicYN="N">Japanese encephalitis virus</Keyword><Keyword MajorTopicYN="N">envelope protein</Keyword><Keyword MajorTopicYN="N">glycosylation</Keyword><Keyword MajorTopicYN="N">vaccine potential</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30042931</ArticleId><ArticleId IdType="pmc">PMC6048278</ArticleId><ArticleId IdType="doi">10.3389/fcimb.2018.00239</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Baranowski E., Ruiz-Jarabo C. M., Domingo E. (2001). Evolution of cell recognition by viruses. Science 292, 1102&#x2013;1105. 10.1126/science.1058613</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1058613</ArticleId><ArticleId IdType="pubmed">11352064</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell G. L., Hills S. L., Fischer M., Jacobson J. A., Hoke C. H., Hombach J. M., et al. . (2011). Estimated global incidence of Japanese encephalitis: a systematic review. Bull. World Health Organ 89, 766&#x2013;774, 774A&#x2212;774E. 10.2471/BLT.10.085233</Citation><ArticleIdList><ArticleId IdType="doi">10.2471/BLT.10.085233</ArticleId><ArticleId IdType="pmc">PMC3209971</ArticleId><ArticleId IdType="pubmed">22084515</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L. K., Lin Y. L., Liao C. L., Lin C. G., Huang Y. L., Yeh C. T., et al. . (1996). Generation and characterization of organ-tropism mutants of Japanese encephalitis virus in vivo and in vitro. Virology 223, 79&#x2013;88. 10.1006/viro.1996.0457</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1996.0457</ArticleId><ArticleId IdType="pubmed">8806542</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S. T., Liu R. S., Wu M. F., Lin Y. L., Chen S. Y., Tan D. T., et al. . (2012). CLEC5A regulates Japanese encephalitis virus-induced neuroinflammation and lethality. PLoS Pathog. 8:e1002655. 10.1371/journal.ppat.1002655</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002655</ArticleId><ArticleId IdType="pmc">PMC3334897</ArticleId><ArticleId IdType="pubmed">22536153</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Maguire T., Hileman R. E., Fromm J. R., Esko J. D., Linhardt R. J., et al. . (1997). Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat. Med. 3, 866&#x2013;871. 10.1038/nm0897-866</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm0897-866</ArticleId><ArticleId IdType="pubmed">9256277</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu J. J., Ng M. L. (2004). Interaction of West Nile virus with &#x3b1;v&#x3b2;3 integrin mediates virus entry into cells. J. Biol. Chem. 279, 54533&#x2013;54541. 10.1074/jbc.M410208200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M410208200</ArticleId><ArticleId IdType="pubmed">15475343</ArticleId></ArticleIdList></Reference><Reference><Citation>Das S., Laxminarayana S. V., Chandra N., Ravi V., Desai A. (2009). Heat shock protein 70 on Neuro2a cells is a putative receptor for Japanese encephalitis virus. Virology 385, 47&#x2013;57. 10.1016/j.virol.2008.10.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2008.10.025</ArticleId><ArticleId IdType="pubmed">19068261</ArticleId></ArticleIdList></Reference><Reference><Citation>Das S., Ravi V., Desai A. (2011). Japanese encephalitis virus interacts with vimentin to facilitate its entry into porcine kidney cell line. Virus Res. 160, 404&#x2013;408. 10.1016/j.virusres.2011.06.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2011.06.001</ArticleId><ArticleId IdType="pubmed">21798293</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis C. W., Mattei L. M., Nguyen H. Y., Ansarah-Sobrinho C., Doms R. W., Pierson T. C. (2006). The location of asparagine-linked glycans on West Nile virions controls their interactions with CD209 (dendritic cell-specific ICAM-3 grabbing nonintegrin). J. Biol. Chem. 281, 37183&#x2013;37194. 10.1074/jbc.M605429200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M605429200</ArticleId><ArticleId IdType="pubmed">17001080</ArticleId></ArticleIdList></Reference><Reference><Citation>Durbin J. E., Hackenmiller R., Simon M. C., Levy D. E. (1996). Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84, 443&#x2013;450. 10.1016/S0092-8674(00)81289-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)81289-1</ArticleId><ArticleId IdType="pubmed">8608598</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan Y. C., Lin J. W., Liao S. Y., Chen J. M., Chen Y. Y., Chiu H. C., et al. . (2017). Virulence of Japanese encephalitis virus genotypes I and III, Taiwan. Emerg. Infect. Dis. 23, 1883&#x2013;1886. 10.3201/eid2311.161443</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2311.161443</ArticleId><ArticleId IdType="pmc">PMC5652437</ArticleId><ArticleId IdType="pubmed">29048288</ArticleId></ArticleIdList></Reference><Reference><Citation>Germi R., Crance J. M., Garin D., Guimet J., Lortat-Jacob H., Ruigrok R. W., et al. . (2002). Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus. Virology 292, 162&#x2013;168. 10.1006/viro.2001.1232</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2001.1232</ArticleId><ArticleId IdType="pubmed">11878919</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanna S. L., Pierson T. C., Sanchez M. D., Ahmed A. A., Murtadha M. M., Doms R. W. (2005). N-linked glycosylation of west nile virus envelope proteins influences particle assembly and infectivity. J. Virol. 79, 13262&#x2013;13274. 10.1128/JVI.79.21.13262-13274.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.21.13262-13274.2005</ArticleId><ArticleId IdType="pmc">PMC1262570</ArticleId><ArticleId IdType="pubmed">16227249</ArticleId></ArticleIdList></Reference><Reference><Citation>Hase T., Dubois D. R., Summers P. L. (1990). Comparative study of mouse brains infected with Japanese encephalitis virus by intracerebral or intraperitoneal inoculation. Int. J. Exp. Pathol. 71, 857&#x2013;869.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2002376</ArticleId><ArticleId IdType="pubmed">2177623</ArticleId></ArticleIdList></Reference><Reference><Citation>Igarashi A. (1978). Isolation of a Singh's Aedes albopictus cell clone sensitive to Dengue and Chikungunya viruses. J. Gen. Virol. 40, 531&#x2013;544. 10.1099/0022-1317-40-3-531</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-40-3-531</ArticleId><ArticleId IdType="pubmed">690610</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J. M., Yun S. I., Song B. H., Hahn Y. S., Lee C. H., Oh H. W., et al. . (2008). A single N-linked glycosylation site in the Japanese encephalitis virus prM protein is critical for cell type-specific prM protein biogenesis, virus particle release, and pathogenicity in mice. J. Virol. 82, 7846&#x2013;7862. 10.1128/JVI.00789-08</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00789-08</ArticleId><ArticleId IdType="pmc">PMC2519568</ArticleId><ArticleId IdType="pubmed">18524814</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn R. J., Zhang W., Rossmann M. G., Pletnev S. V., Corver J., Lenches E., et al. . (2002). Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108, 717&#x2013;725. 10.1016/S0092-8674(02)00660-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(02)00660-8</ArticleId><ArticleId IdType="pmc">PMC4152842</ArticleId><ArticleId IdType="pubmed">11893341</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee E., Lobigs M. (2000). Substitutions at the putative receptor-binding site of an encephalitic flavivirus alter virulence and host cell tropism and reveal a role for glycosaminoglycans in entry. J. Virol. 74, 8867&#x2013;8875. 10.1128/JVI.74.19.8867-8875.2000</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.19.8867-8875.2000</ArticleId><ArticleId IdType="pmc">PMC102081</ArticleId><ArticleId IdType="pubmed">10982329</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee E., Hall R. A., Lobigs M. (2004). Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses. J. Virol. 78, 8271&#x2013;8280. 10.1128/JVI.78.15.8271-8280.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.15.8271-8280.2004</ArticleId><ArticleId IdType="pmc">PMC446099</ArticleId><ArticleId IdType="pubmed">15254199</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang J. J., Liao C. L., Liao J. T., Lee Y. L., Lin Y. L. (2009). A Japanese encephalitis virus vaccine candidate strain is attenuated by decreasing its interferon antagonistic ability. Vaccine 27, 2746&#x2013;2754. 10.1016/j.vaccine.2009.03.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2009.03.007</ArticleId><ArticleId IdType="pubmed">19366580</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang J. J., Yu C. Y., Liao C. L., Lin Y. L. (2011). Vimentin binding is critical for infection by the virulent strain of Japanese encephalitis virus. Cell. Microbiol. 13, 1358&#x2013;1370. 10.1111/j.1462-5822.2011.01624.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1462-5822.2011.01624.x</ArticleId><ArticleId IdType="pubmed">21707907</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindenbach B. D., Thiel H.-J., Rice C. M. (2007). Flaviviridae: the viruses and their replication, in Fields Virology, 5th Edn., eds Knipe D. M., Howley P. M. (Philadelphia, PA: Lippincott Williams &amp; Wilkins, a Wolters Kluwer Business; ), 1101&#x2013;1152.</Citation></Reference><Reference><Citation>Makarova O., Kamberov E., Margolis B. (2000). Generation of deletion and point mutations with one primer in a single cloning step. Biotechniques 29, 970&#x2013;972.</Citation><ArticleIdList><ArticleId IdType="pubmed">11084856</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondotte J. A., Lozach P. Y., Amara A., Gamarnik A. V. (2007). Essential role of dengue virus envelope protein N glycosylation at asparagine-67 during viral propagation. J. Virol. 81, 7136&#x2013;7148. 10.1128/JVI.00116-07</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00116-07</ArticleId><ArticleId IdType="pmc">PMC1933273</ArticleId><ArticleId IdType="pubmed">17459925</ArticleId></ArticleIdList></Reference><Reference><Citation>Moudy R. M., Zhang B., Shi P. Y., Kramer L. D. (2009). West Nile virus envelope protein glycosylation is required for efficient viral transmission by Culex vectors. Virology 387, 222&#x2013;228. 10.1016/j.virol.2009.01.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2009.01.038</ArticleId><ArticleId IdType="pmc">PMC2742948</ArticleId><ArticleId IdType="pubmed">19249803</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukhopadhyay S., Kuhn R. J., Rossmann M. G. (2005). A structural perspective of the flavivirus life cycle. Nat. Rev. Microbiol. 3, 13&#x2013;22. 10.1038/nrmicro1067</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro1067</ArticleId><ArticleId IdType="pubmed">15608696</ArticleId></ArticleIdList></Reference><Reference><Citation>NSC (2004). &#x57fa;&#x56e0;&#x91cd;&#x7d44;&#x5be6;&#x9a57;&#x5b88;&#x5247; &#x201c;Guidelines of for research involving recombinant DNA molecules,&#x201d; Appendix II, Risk Factor group 2 (Taipei: ), 51.</Citation></Reference><Reference><Citation>Pokidysheva E., Zhang Y., Battisti A. J., Bator-Kelly C. M., Chipman P. R., Xiao C., et al. . (2006). Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN. Cell 124, 485&#x2013;493. 10.1016/j.cell.2005.11.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2005.11.042</ArticleId><ArticleId IdType="pubmed">16469696</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed L. J., Muench H. (1938). A simple method of estimating fifty per cent endpoints12. Am. J. Epidemiol. 27, 493&#x2013;497. 10.1093/oxfordjournals.aje.a118408</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a118408</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakuntabhai A., Turbpaiboon C., Casad&#xe9;mont I., Chuansumrit A., Lowhnoo T., Kajaste-Rudnitski A., et al. . (2005). A variant in the CD209 promoter is associated with severity of dengue disease. Nat. Genet. 37, 507&#x2013;513. 10.1038/ng1550</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1550</ArticleId><ArticleId IdType="pmc">PMC7096904</ArticleId><ArticleId IdType="pubmed">15838506</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimojima M., Takenouchi A., Shimoda H., Kimura N., Maeda K. (2014). Distinct usage of three C-type lectins by Japanese encephalitis virus: DC-SIGN, DC-SIGNR, and LSECtin. Arch. Virol. 159, 2023&#x2013;2031. 10.1007/s00705-014-2042-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-014-2042-2</ArticleId><ArticleId IdType="pmc">PMC7087284</ArticleId><ArticleId IdType="pubmed">24623090</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirohi D., Kuhn R. J. (2017). Zika virus structure, maturation, and receptors. J. Infect. Dis. 216, S935&#x2013;S944. 10.1093/infdis/jix515</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jix515</ArticleId><ArticleId IdType="pmc">PMC5853281</ArticleId><ArticleId IdType="pubmed">29267925</ArticleId></ArticleIdList></Reference><Reference><Citation>Su C. M., Liao C. L., Lee Y. L., Lin Y. L. (2001). Highly sulfated forms of heparin sulfate are involved in Japanese encephalitis virus infection. Virology 286, 206&#x2013;215. 10.1006/viro.2001.0986</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2001.0986</ArticleId><ArticleId IdType="pubmed">11448173</ArticleId></ArticleIdList></Reference><Reference><Citation>Tassaneetrithep B., Burgess T. H., Granelli-Piperno A., Trumpfheller C., Finke J., Sun W., et al. . (2003). DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J. Exp. Med. 197, 823&#x2013;829. 10.1084/jem.20021840</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20021840</ArticleId><ArticleId IdType="pmc">PMC2193896</ArticleId><ArticleId IdType="pubmed">12682107</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kooyk Y., Geijtenbeek T. B. (2003). DC-SIGN: escape mechanism for pathogens. Nat. Rev. Immunol. 3, 697&#x2013;709. 10.1038/nri1182</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri1182</ArticleId><ArticleId IdType="pubmed">12949494</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kooyk Y., Unger W. W., Fehres C. M., Kalay H., Garc&#xed;a-Vallejo J. J. (2013). Glycan-based DC-SIGN targeting vaccines to enhance antigen cross-presentation. Mol. Immunol. 55, 143&#x2013;145. 10.1016/j.molimm.2012.10.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2012.10.031</ArticleId><ArticleId IdType="pubmed">23158834</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P., Hu K., Luo S., Zhang M., Deng X., Li C., et al. . (2016). DC-SIGN as an attachment factor mediates Japanese encephalitis virus infection of human dendritic cells via interaction with a single high-mannose residue of viral E glycoprotein. Virology 488, 108&#x2013;119. 10.1016/j.virol.2015.11.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2015.11.006</ArticleId><ArticleId IdType="pubmed">26629951</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiteman M. C., Li L., Wicker J. A., Kinney R. M., Huang C., Beasley D. W., et al. . (2010). Development and characterization of non-glycosylated E and NS1 mutant viruses as a potential candidate vaccine for West Nile virus. Vaccine 28, 1075&#x2013;1083. 10.1016/j.vaccine.2009.10.112</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2009.10.112</ArticleId><ArticleId IdType="pubmed">19896447</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO (2016). Japanese encephalitis vaccines: WHO position paper, February 2015&#x2013;Recommendations. Vaccine 34, 302&#x2013;303. 10.1016/j.vaccine.2015.07.057</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.07.057</ArticleId><ArticleId IdType="pubmed">26232543</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F., Ren S., Zuo Y. (2014). DC-SIGN, DC-SIGNR and LSECtin: C-type lectins for infection. Int. Rev. Immunol. 33, 54&#x2013;66. 10.3109/08830185.2013.834897</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08830185.2013.834897</ArticleId><ArticleId IdType="pubmed">24156700</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Chen P., Cao R., Gu J. (2011). Mutation of putative N-linked glycosylation sites in Japanese encephalitis virus premembrane and envelope proteins enhances humoral immunity in BALB/C mice after DNA vaccination. Virol. J. 8:138. 10.1186/1743-422X-8-138</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-8-138</ArticleId><ArticleId IdType="pmc">PMC3088903</ArticleId><ArticleId IdType="pubmed">21439032</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>